MDX small RNA sequencing products are compatible with Illumina sequencing technology and designed for the simplest, the most economical, the most precise and automated small RNA library preparation, enabling a great elimination of sequencing errors and biases.
Innovative MultiplexDX DNA/RNA FISH technologies allow simultaneous visualization of 8 and more biomarkers, using the simplest FISH protocols and the most stable, target-specific FISH probes and reagents. It overcomes current limitations and increases cost-, time-, and labor-effectiveness of DNA/RNA FISH by improving the probe design and automating the probes synthesis.
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining our proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient allowing clinicians to suggest specific personalized cancer treatment.